Drug Induced Interstitial Lung Disease
Top Cited Papers
Open Access
- 27 July 2012
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Respiratory Medicine Journal
- Vol. 6 (1), 63-74
- https://doi.org/10.2174/1874306401206010063
Abstract
With an increasing number of therapeutic drugs, the list of drugs that is responsible for severe pulmonary disease also grows. Many drugs have been associated with pulmonary complications of various types, including interstitial inflammation and fibrosis, bronchospasm, pulmonary edema, and pleural effusions. Drug-induced interstitial lung disease (DILD) can be caused by chemotherapeutic agents, antibiotics, antiarrhythmic drugs, and immunosuppressive agents. There are no distinct physiologic, radiographic or pathologic patterns of DILD, and the diagnosis is usually made when a patient with interstitial lung disease (ILD) is exposed to a medication known to result in lung disease. Other causes of ILD must be excluded. Treatment is avoidance of further exposure and systemic corticosteroids in patients with progressive or disabling disease.Keywords
This publication has 105 references indexed in Scilit:
- Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009Journal of the Royal Society of Medicine, 2010
- Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registryArthritis & Rheumatism, 2009
- Pleuropulmonary Toxicity of Another Anti-Parkinson`s Drug: CabergolineThe Open Respiratory Medicine Journal, 2009
- Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-EpisodesPLOS ONE, 2009
- Role of Cytochrome P450 Polymorphisms in the Development of Pulmonary Drug ToxicityDrug Safety, 2008
- Incidence of fatal adverse drug reactions: a population based studyBritish Journal of Clinical Pharmacology, 2007
- Neglected Respiratory Toxicity Caused by Cancer TherapyThe Open Respiratory Medicine Journal, 2007
- Influence of CYP2C9 and VKORC1 1173C/T Genotype on the Risk of Hemorrhagic Complications in African-American and European-American Patients on WarfarinClinical Pharmacology & Therapeutics, 2007
- Adverse drug reactions result in 250 000 UK admissions a yearBMJ, 2006
- Pulmonary Function Testing in Interstitial Lung DiseasesRespiration, 2004